On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

CBD Market Steadiness Buoys HempFusion Wellness Inc. (TSX: CBD.U) (OTC: CBDHF) Hopes as TSX Launch Completed

  • Health and wellness company HempFusion Wellness, Inc. launched its IPO Jan. 6 with the ticker CBD.U, and also trades in the US under the symbol CBDHF
  • The company distributes its brands HempFusion, Probulin Probiotics, Biome Research and HF Labs to 4,000 retailers in every state as well as select international locales, and is strategically planning for expansion
  • Despite the economic battering some industries have experienced as a result of the global pandemic, hemp and CBD continue to see consumer use trends holding stable with forecasts for new market growth in coming years
  • HempFusion is focused on regulatory compliance with industry safety and quality standards, and is also a lead sponsor and participant in CBD liver-impact study
  • HempFusion has been included in two leading cannabis & hemp-derived CBD focused exchange- ETFs, AdvisorShares Pure US Cannabis ETF (NYSE: MSOS) and AdvisorShares Pure Cannabis ETF (NYSE: YOLO)

On Jan. 6, HempFusion Wellness (TSX: CBD.U) (OTC: CBDHF) launched an IPO and listing of its common shares and certain other securities on Canada’s TSX exchange, making the company the first U.S.-based cannabidiol (“CBD”) product manufacturer to list on the TSX as it snared the ticker CBD.U (https://cnw.fm/IAeAA). Subsequently the company received its US symbol: CBDHF.

Amid the spread of pandemic conditions worldwide, hemp farmers found their robust expectations of a “green rush” following legalization efforts in the United States to be in a cooling trend, largely because of an oversupplied market as the agricultural industry sorts out its balance point in an emerging product phase (https://cnw.fm/EP00v).

Even so, surveys have found that hemp and CBD use trends are continuing on point, possibly as a result of individuals’ efforts to manage stresses related to the health crisis, its economic fallout, and contentious politically motivated parties circling the field (https://cnw.fm/N2VQb).

The steadiness of the hemp consumer trends and the potential for a new rush rebound once pandemic-spawned social restrictions subside are good news for companies like Denver-based HempFusion Wellness, which incorporated in late 2015 and has seen its sails fill over the past four years as strategic acquisition and relentless retail channel penetration have driven its revenues upward.

The pandemic has forced consumers to rely more heavily than ever on e-commerce and Internet-based video communication platforms to conduct business and manage personnel remotely, which in turn has created ample opportunity for young companies to compete so long as they can manage the challenges of production pace while they attempt to scale up.

HempFusion’s CBD and probiotic products include a family of brands such as HempFusion, Probulin Probiotics, Biome Research and HF Labs, that are distributed to approximately 4,000 retailers in every state as well as select international locales. The company is strategically planning its expansion to potentially add a variety of product offerings including CBD-based beverages, edibles, pet products and more.

Grandview Research analysts anticipate that CBD-based pet products will see a CAGR of 40.3 percent between 2020 and 2027 (https://cnw.fm/t7aLC), while Data Bridge Market Research predicts CBD edibles will grow at a CAGR of 24.30 percent during the same period (https://cnw.fm/IkYhM).

The CBD-based beverage market, still in its infancy, grew 168 percent YOY between December 2018 and 2019, according to BDS Analytics (https://cnw.fm/BVyGs) and Grandview Research notes the sector is expected to grow at a CAGR of 17.8 percent through 2025.

Among the condition-specific OTC product markets where HempFusion is now operating, pain products are projected to see a CAGR of 7.4 percent between 2018 and 2025, eczema products are predicted to increase to $13.6 billion by 2026, the acne and beauty product sector is already estimated at $1.08 trillion and the first aid products segment was generating over $650 million in sales as of last year’s report (https://cnw.fm/s4Rtx).

“Completion of (the) … initial public offering will accelerate our ability to scale HempFusion’s operations both domestically and internationally, drive accelerated growth within all our distribution channels, and significantly expand our marketing initiatives,” CEO Dr. Jason Mitchell stated recently (https://cnw.fm/OH2kD).

For more information, visit the company’s website at www.HempFusion.com/Corporate-Information and contact the team at ir@hempfusion.com.

NOTE TO INVESTORS: The latest news and updates relating to HempFusion are available in the company’s newsroom at https://cnw.fm/HempFusion

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Archives

Select A Month

Official NewsWire Relationships

Alternative Products Expo Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition Cannexpo Marigold PR MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo Tether BudTender Tether BudTender Appreciation Week

CannabisNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722